PMV PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
PMV PHARMACEUTICALS, INC. (PMVP) had Shares Outstanding (Cover Page) of 53.46 million shares as of 2026-08-14, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-14: Entity Common Stock, Shares Outstanding 53.46M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 53.33M shares.
- 2026-03-03: Entity Common Stock, Shares Outstanding 53.33M shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 53.21M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-14 | 53.46M shares 10-Q · filed 2026-08-14 |
| 2026-05-12 | 53.33M shares 10-Q · filed 2026-05-12 |
| 2026-03-03 | 53.33M shares 10-K · filed 2026-03-06 |
| 2025-11-12 | 53.21M shares 10-Q · filed 2025-11-12 |
| 2025-08-07 | 52.99M shares 10-Q · filed 2025-08-07 |
| 2025-05-09 | 51.95M shares 10-Q · filed 2025-05-09 |
| 2025-03-03 | 51.93M shares 10-K · filed 2025-03-03 |
| 2024-11-06 | 51.75M shares 10-Q · filed 2024-11-07 |
| 2024-08-07 | 51.52M shares 10-Q · filed 2024-08-08 |
| 2024-05-08 | 51.44M shares 10-Q · filed 2024-05-09 |
| 2024-02-28 | 51.44M shares 10-K · filed 2024-02-29 |
| 2023-11-07 | 51.16M shares 10-Q · filed 2023-11-09 |
| 2023-08-07 | 48.45M shares 10-Q · filed 2023-08-09 |
| 2023-05-08 | 45.78M shares 10-Q · filed 2023-05-10 |
| 2023-02-24 | 45.77M shares 10-K · filed 2023-03-01 |
| 2022-11-08 | 45.67M shares 10-Q · filed 2022-11-08 |
| 2022-08-09 | 45.62M shares 10-Q · filed 2022-08-09 |
| 2022-05-06 | 45.57M shares 10-Q · filed 2022-05-10 |
| 2022-02-25 | 45.45M shares 10-K · filed 2022-03-01 |
| 2021-11-10 | 45.38M shares 10-Q · filed 2021-11-12 |
| 2021-08-12 | 45.29M shares 10-Q · filed 2021-08-13 |
| 2021-05-12 | 45.03M shares 10-Q · filed 2021-05-14 |
| 2021-02-28 | 44.78M shares 10-K · filed 2021-03-03 |
| 2020-11-01 | 44.77M shares 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |